कृपया अन्य खोज का प्रयास करें
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company’s proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington’s disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington’s disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Robert Zamboni | - | - | Chief of Preclinical Development & Member of Scientific Advisory Board |
Dov A. Goldstein | 55 | 2019 | Independent Chairperson |
Eric I. Richman | 62 | 2019 | Independent Director |
Robert Friedlander | - | - | Chair of Scientific Advisory Board |
George McDonald Church | 69 | 2023 | Chairperson of Gene Editing Advisory Board & Member of Scientific Advisory Board |
Peter Nielsen | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Randy Davis | - | 2020 | Member of Scientific Advisory Board |
Eriks Rozners | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Gerald J. Mcdougall | 56 | 2021 | Independent Director |
Danith H. Ly | - | 2019 | Member of Advisory Board |
Steven F. Dowdy | - | 2019 | Member of Gene Editing & Scientific Advisory Board |
James M. Coull | - | 2023 | Member of Gene Editing Advisory Board |
Jeremy Stark | - | 2023 | Member of Gene Editing Advisory Board |
Dietrich A. Stephan | 54 | 2019 | Founder, President & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है